Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07340814

A Long-term Follow-up Study of Patients Who Received MB-105

This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Any Patient Treated With MB-105

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

This study is for long term follow up of efficacy and safety for any patient treated with MB-105 who has consented to joining the LTFU study. There are no exclusion criteria.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Received MB-105 Signed informed consent Agree to transfer of samples from previous study Able to comply with study requirements

Exclusion criteria

N/A

Treatment and study plan

MB-105

Biological

This is an observational study with no study product administered because it is the LTFU study for patients who received the product in another study

Primary outcomes

  1. Assess long term safety of MB-105 in patients who received MB-105

    Time frame: 15 Years

    SAEs

Secondary outcomes

  1. Assess long term efficacy of MB-105 in patients who received MB-105

    Time frame: 15 Years

    Time to progression/relapse in those who have not yet relapsed and overall survival

Sponsors and collaborators

Lead sponsor

March Biosciences Inc

Industry

Registry information

Important dates

Study start
2026
Primary completion
2040
Study completion
2040
First posted
Jan 14, 2026
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.